Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PURE BiosciencePURE +13.17% 5-Year ROIIC % is 236.84 as of Jul. 2025. The stock has 5 warning signs investors should review. Among 1,707 Consumer Packaged Goods companies, PURE Bioscience ranks better than 96.78% on this metric.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
PURE Bioscience's 5-Year ROIIC % for the quarter that ended in Jul. 2025 was 236.84%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for PURE Bioscience's 5-Year ROIIC % or its related term are showing as below:
PURE's 5-Year ROIIC % is ranked better than 96.78% of 1707
companies
in the Consumer Packaged Goods industry
Industry Median: 3.55
vs PURE: 236.84
PURE Bioscience (OTCPK:PURE) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
PURE Bioscience 5-Year ROIIC % Related Terms
PURE Bioscience 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for PURE Bioscience's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PURE vs DQWS, RAY, TANH: 5-Year ROIIC % Comparison
For the Household & Personal Products subindustry, PURE Bioscience's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PURE Bioscience 5-Year ROIIC % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, PURE Bioscience's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where PURE Bioscience's 5-Year ROIIC % falls into.
PURE Bioscience's 5-Year ROIIC % for the quarter that ended in Jul. 2025 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( -2.272 (Jul. 2025) - 0.004 (Jul. 2020) )
/
( 0.011 (Jul. 2025) - 0.972 (Jul. 2020) )
=
-2.276
/
-0.961
=
236.84%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
PURE Bioscience (PURE) has a 5-Year ROIIC % of 236.84 as of Jul. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on PURE Bioscience and its competitors. According to the industry distribution chart, PURE Bioscience ranks #55 out of 1707 companies in the Consumer Packaged Goods industry, placing it in the top 3.2%.
Is PURE Bioscience's 5-Year ROIIC % too high?
PURE Bioscience's current 5-Year ROIIC % is 236.84. The Consumer Packaged Goods industry median 5-Year ROIIC % is 3.55. PURE Bioscience's value of 236.84 is 6571.5% above this industry median. Based on the distribution chart, PURE Bioscience ranks #55 out of 1707 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers.
How does PURE Bioscience's 5-Year ROIIC % compare to DQWS and RAY?
According to the Consumer Packaged Goods industry distribution chart, PURE Bioscience ranks #55 out of 1707 companies for 5-Year ROIIC %. This places PURE Bioscience in the top 3% of its industry — outperforming the majority of peers. The industry median 5-Year ROIIC % is 3.55. PURE Bioscience's value of 236.84 is 6571.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Consumer Packaged Goods company?
The median 5-Year ROIIC % among Consumer Packaged Goods companies is 3.55, based on 1,707 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PURE Bioscience's current 5-Year ROIIC % of 236.84 is 6571.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on PURE Bioscience and its competitors. For the Consumer Packaged Goods industry, the median 5-Year ROIIC % is 3.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PURE Bioscience's current 5-Year ROIIC % is 236.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PURE Bioscience stock overvalued right now?
Based on GuruFocus' analysis, PURE Bioscience (PURE) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.10, compared to a current price of $0.08 — trading 23.3% below its estimated fair value. The current 5-Year ROIIC % is 236.84 and 6571.5% above the Consumer Packaged Goods industry median of 3.55. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For PURE Bioscience (PURE), the current 5-Year ROIIC % is 236.84 as of Jul. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The company generates revenue from the sale of its antimicrobial products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PURE has been successfully added to your 
